Preoperative dual antiplatelet therapy increases risk after urgent coronary bypass surgery: A Netherlands heart

Heleen J C L Apostel1, Maaike M Roefs2, Amon Heijne3

  • 1Department of Anesthesia, Pain and Palliative Medicine, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.

JTCVS Open
|December 31, 2025
PubMed

Insights

Dual antiplatelet therapy before urgent coronary artery bypass grafting increases bleeding and mortality risks. Inconsistent practices highlight the need for standardized guidelines for managing patients with acute coronary syndrome undergoing surgery.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Clinical Research

Background:

  • Dual antiplatelet therapy (DAPT) is standard post-acute coronary syndrome (ACS).
  • Perioperative management of DAPT before urgent coronary artery bypass grafting (CABG) is controversial.
  • Optimal antiplatelet strategies for ACS patients needing urgent CABG require clarification.

Purpose of the Study:

  • To assess the impact of preoperative DAPT on surgical and postoperative outcomes.
  • To evaluate outcomes in patients undergoing urgent CABG after ACS.
  • To analyze the association between recent DAPT and outcomes in urgent CABG patients.

Main Methods:

  • Retrospective cohort study of 6913 patients undergoing urgent isolated CABG within 90 days of ACS.
  • Comparison of patients on DAPT (aspirin + P2Y12 inhibitor within 48 hours preoperatively) versus aspirin alone.
  • Propensity score matching and multivariable logistic regression for confounding adjustment.

Main Results:

  • Recent DAPT use was independently associated with increased perioperative bleeding complications.
  • Higher rates of reintervention (OR, 1.78), transfusion (OR, 1.85), and surgical mortality (OR, 2.02) were observed with DAPT.
  • Significant interhospital variation in DAPT use (12%-84%) indicated inconsistent practices.

Conclusions:

  • Recent DAPT before urgent CABG significantly increases perioperative bleeding risk, transfusion needs, and mortality.
  • Substantial variation in DAPT use across centers necessitates standardized, evidence-based guidelines.
  • Optimizing antiplatelet management is crucial for high-risk ACS patients undergoing surgical revascularization.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
350
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
347
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
217
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
214